Covered recipient · General Payments record
ALAN ZWEBEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,181.00
- Reported across 256 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $492.60 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $146.94 | 7 |
| Novo Nordisk AS | $101.80 | 6 |
| ABBVIE INC. | $74.51 | 3 |
| Astellas Pharma US Inc | $65.80 | 3 |
| PFIZER INC. | $24.08 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.51 | 1 |
| EISAI INC. | $21.46 | 1 |
| GlaxoSmithKline, LLC. | $20.58 | 1 |
| Acerta Pharma LLC | $14.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.13 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402625 | CMS |
| ABBVIE INC. | $18.54 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402627 | CMS |
| ABBVIE INC. | $27.84 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402629 | CMS |
| Astellas Pharma US Inc | $17.97 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139306548 | CMS |
| Astellas Pharma US Inc | $23.22 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139375918 | CMS |
| Astellas Pharma US Inc | $24.61 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139429746 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.92 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104774180 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $22.51 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086239268 | CMS |
| Eisai Inc. | $21.46 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110727403 | CMS |
| GlaxoSmithKline, LLC. | $20.58 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116477396 | CMS |
| Lilly USA, LLC | $11.76 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136008393 | CMS |
| Lilly USA, LLC | $20.07 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136014050 | CMS |
| Lilly USA, LLC | $23.33 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015167 | CMS |
| Lilly USA, LLC | $23.11 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012723 | CMS |
| Lilly USA, LLC | $29.23 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136011613 | CMS |
| Lilly USA, LLC | $15.36 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136015169 | CMS |
| Lilly USA, LLC | $24.08 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136014052 | CMS |
| Novo Nordisk Inc | $17.99 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096716426 | CMS |
| Novo Nordisk Inc | $18.66 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096666958 | CMS |
| Novo Nordisk Inc | $16.64 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097494289 | CMS |
| Novo Nordisk Inc | $15.61 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096583942 | CMS |
| Novo Nordisk Inc | $15.50 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097249456 | CMS |
| Novo Nordisk Inc | $17.40 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096623060 | CMS |
| PFIZER INC. | $24.08 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131197478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.